Korean J Urol.  2015 Jun;56(6):422-428. 10.4111/kju.2015.56.6.422.

Incidence of kidney, bladder, and prostate cancers in Korea: An update

Affiliations
  • 1Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. hwanggyun.jeon@samsung.com

Abstract

The incidence of cancer is sharply increasing. Cancer is a leading cause of death as well as a significant burden on society. The incidence of urological cancer has shown a higher than average increase and will become an important concern in the future. Therefore, an overall and accurate understanding of the incidence of urological cancer is essential. In this study, which was based on the Korea National Cancer Incidence Database, annual incident cases, age-standardized incidence rates, annual percentage change (APC), and distribution by age group were examined in kidney, bladder, and prostate cancers, respectively. From 1999 to 2011, the total number of each type of urological cancer was as follows: kidney cancer (32,600 cases, 25.5%), bladder cancer (37,950 cases, 29.7%), and prostate cancer (57,332 cases, 44.8%). The age-standardized incidence rates of prostate cancer showed a significant increase with an APC of 12.3% in males. Kidney cancer gradually increased with an APC of 6.0% for both sexes and became the second most frequent urological cancer after 2008. Bladder cancer showed no significant change with an APC of -0.2% for both sexes and has decreased slightly since 2007. The distribution of kidney cancer according to age showed two peaks in the 50- to 54-year-old and 65- to 69-year-old age groups. Bladder and prostate cancers occurred mostly in the 70- to 74-year-old age group. The proportions of male to female were 2.5:1 in kidney cancer and 5.6:1 in bladder cancer. We have summarized the incidence trends of kidney, bladder, and prostate cancers and have provided useful information for screening and management of these cancers in the future.

Keyword

Incidence; Kidney; Neoplasms; Prostate; Urinary bladder

MeSH Terms

Female
Humans
Incidence
Kidney Neoplasms/epidemiology
Male
Prostatic Neoplasms/epidemiology
Republic of Korea/epidemiology
Urinary Bladder Neoplasms/epidemiology
Urogenital Neoplasms/*epidemiology

Figure

  • Fig. 1 Trend in age-standardized cancer incidence rates according to site (A) and sex in kidney (B) and bladder (C). APC, annual percentage change.

  • Fig. 2 The distribution of kidney cancer incidence according to age group. (A) Annual change from 2006 to 2010. (B) Sum of 5-year cancer incidence. (C) Sex comparisons.

  • Fig. 3 The distribution of bladder cancer incidence according to age group. (A) Annual change from 2006 to 2010. (B) Sum of 5-year cancer incidence. (C) Sex comparisons.

  • Fig. 4 The distribution of prostate cancer incidence according to age group. (A) Annual change from 2006 to 2010. (B) Sum of 5-year cancer incidence.


Cited by  7 articles

Recent Trends in Transurethral Surgeries and Urological Outpatient Procedures: a Nationwide Population-based Cohort Study
Jong Keun Kim, Changil Choi, Ui Seok Kim, Hyosang Kwon, Seong Ho Lee, Young Goo Lee, Jun Hyun Han
J Korean Med Sci. 2020;35(38):e315.    doi: 10.3346/jkms.2020.35.e315.

National Trend of Uroflowmetry, Urodynamic Study and Cystoscopy Considering the Change in the Population Structure in Korea from 2010 to 2015
Min Jung Baek, Suyeon Park, Ki Hyun Kim, Yune Hyoun Kim, Woo Ki Kim, Hwa Yeon Sun, Jae Heon Kim
J Korean Med Sci. 2018;33(20):.    doi: 10.3346/jkms.2018.33.e145.

Curative resection of bladder cancer with pancreas head metastasis
Young Mok Park, Hyung-Il Seo, Seung Baek Hong, Suk Kim, Tae-Nam Kim, So Jeong Lee
Ann Hepatobiliary Pancreat Surg. 2021;25(3):440-444.    doi: 10.14701/ahbps.2021.25.3.440.

Trends in Prostate Cancer Prevalence and Radical Prostatectomy Rate according to Age Structural Changes in South Korea between 2005 and 2015
Hyun Young Lee, Suyeon Park, Seung Whan Doo, Won Jae Yang, Yun Seob Song, Jae Heon Kim
Yonsei Med J. 2019;60(3):257-266.    doi: 10.3349/ymj.2019.60.3.257.

Regulated sandbox and disease-related genetic tests as a direct-to-consumer test
Jong-Won Kim
J Korean Med Assoc. 2019;62(5):240-242.    doi: 10.5124/jkma.2019.62.5.240.

Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea
Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Hyunsoon Cho, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won
Cancer Res Treat. 2017;49(3):607-615.    doi: 10.4143/crt.2016.139.

Time Trends for Prostate Cancer Incidence from 2003 to 2013 in South Korea: An Age-Period-Cohort Analysis
Hyun Young Lee, Do Kyoung Kim, Seung Whan Doo, Won Jae Yang, Yun Seob Song, Bora Lee, Jae Heon Kim
Cancer Res Treat. 2020;52(1):301-308.    doi: 10.4143/crt.2019.194.


Reference

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69–90.
2. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014; 46:109–123.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62:10–29.
4. Cheon J, Kim CS, Lee ES, Hong SJ, Cho YH, Shin EC, et al. Survey of incidence of urological cancer in South Korea: a 15-year summary. Int J Urol. 2002; 9:445–454.
5. Jung KW, Won YJ, Park S, Kong HJ, Sung J, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci. 2009; 24:995–1003.
6. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci. 2010; 25:1113–1121.
7. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011; 43:1–11.
8. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44:11–24.
9. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat. 2013; 45:1–14.
10. Fritz A. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization;2000.
11. World Health Organization. International statistical classification of diseases and related health problems. 10th revision ed. Geneva: World Health Organization;1994.
12. Tyson MD, Humphreys MR, Parker AS, Thiel DD, Joseph RW, Andrews PE, et al. Age-period-cohort analysis of renal cell carcinoma in United States adults. Urology. 2013; 82:43–47.
13. De P, Otterstatter MC, Semenciw R, Ellison LF, Marrett LD, Dryer D. Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007. Cancer Causes Control. 2014; 25:1271–1281.
14. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010; 7:245–257.
15. King SC, Pollack LA, Li J, King JB, Master VA. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. J Urol. 2014; 191:1665–1670.
16. Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, et al. An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol. 2013; 43:492–507.
17. Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A. International variations in bladder cancer incidence and mortality. Eur Urol. 2014; 66:59–73.
18. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013; 63:234–241.
19. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 2011; 29:457–463.
20. Horstmann M, Witthuhn R, Falk M, Stenzl A. Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med. 2008; 5:385–394.
21. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008; 100:1672–1694.
22. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012; 61:1079–1092.
23. Cook MB, Rosenberg PS, McCarty FA, Wu M, King J, Eheman C, et al. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008. Prostate. 2015; 75:758–763.
24. Li J, Djenaba JA, Soman A, Rim SH, Master VA. Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007. Prostate Cancer. 2012; 2012:691380.
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr